Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases
Update: 2021-07-29
Description
In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies.
Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
Related content:
https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272
Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
Related content:
https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272
https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
